The US National Institutes of Health has ended its ban on gain-of-function viral research and unveiled a framework for reviewing such work.
Samples collected at live poultry markets in China identified birds carrying several low pathogenic avian influenza virus subtypes and various mixed infections.
Sekisui will distribute Mesa's point-of-care molecular system for flu A/fB in the US and Canada, pending approval from regulators.
The Universal Influenza Vaccine Initiative, led by Vanderbilt and the Human Vaccines Project, has turned to omics and AI to create more effective flu vaccines.
Berg will use its Interrogative Biology platform in order to assess potential biomarkers of seasonal influenza vaccination outcomes.
The multiplexed assay is the second available on the Panther Fusion system and the FDA is reviewing a third, the Panther Fusion AdV/hMPV/RV assay.
University of Chicago researchers combined epidemiological and viral gene evolution data to refine influenza modeling.
In PLOS this week: transcriptome study of a cold-tolerant plant, deep sequencing of clinical influenza A samples, and more.
The assay runs on the Panther Fusion system, which combines transcription-mediated amplification, real-time TMA, and real-time PCR with full sample-to-result automation.
The firm said that it will soon apply for a CLIA waiver of the second-generation test,which can report positive results in as little as five minutes
A man has confessed to the rape and murder of developmental biologist Suzanne Eaton, according to the New York Times.
The Irish Times reports that US lawmakers and law enforcement agencies are concerned about ties between the US and Chinese genomics firms.
Parents of children with spinal muscular atrophy tell the Washington Post they are pushing to get insurance coverage of Novartis's Zolgensma.
In PNAS this week: gene mutations in individuals with syndromic craniosynostosis, putative colorectal cancer drivers, and more.